EGFR Inhibitor Therapy in Second Line
http://cancerGRACE.org/...
Dr. David Gerber, University of Texas-Southwestern, discusses results of two important trials of maintenance therapy in advanced NSCLC, including the PRONOUNCE trial and POI...
Author: cancergrace
Added: 08/21/2013
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts